Aztreonam
- Product NDC
- 63323-402
- 11-digit product format
- 633230402
- Labeler code
- 63323
- Product ID
- 63323-402_6cd42e51-1a5d-4c6a-8881-0cbde3ca8d70
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- AZTREONAM
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA065439
- Marketing category
- ANDA
- Marketing start
- 2009-11-05
- Substance
- AZTREONAM
- Active strength
- 2 g/1
- Pharmacologic classes
- Monobactam Antibacterial [EPC], Monobactams [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Aztreonam
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AZTREONAM | 2 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | G2B4VE5GH8 |
| Rxcui | 1664981, 1664986 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-402-01 | Aztreonam | 1 in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | | 9 |
| 63323-402-20 | Aztreonam | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | | 9 |
| 63323-402-24 | Aztreonam | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | | 6 |
| 63323-402-41 | Aztreonam | 1 in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | | 6 |
| 63323-402-03 | Aztreonam | 1 in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | | 4 |
| 63323-402-30 | Aztreonam | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | | 4 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| AZTREONAM | ACTIVE INGREDIENT | G2B4VE5GH8 | AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 | |
| AZTREONAM | ACTIVE MOIETY | G2B4VE5GH8 | AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 | |
| ARGININE | INACTIVE INGREDIENT | 94ZLA3W45F | AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 | |
| AZTREONAM | ACTIVE INGREDIENT | G2B4VE5GH8 | AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| AZTREONAM | ACTIVE MOIETY | G2B4VE5GH8 | AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| ARGININE | INACTIVE INGREDIENT | 94ZLA3W45F | AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| AZTREONAM | ACTIVE INGREDIENT | G2B4VE5GH8 | AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| AZTREONAM | ACTIVE MOIETY | G2B4VE5GH8 | AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| ARGININE | INACTIVE INGREDIENT | 94ZLA3W45F | AZTREONAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-402 | AZTREONAM (AZTREONAM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC
] | 9 | Current NDC, Legacy NDC, 2 package rows | 20220412_c6cf7e13-a04e-47e2-9cec-44a278ee6bec.zip |
| 63323-402 | AZTREONAM (AZTREONAM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC
] | 6 | Current NDC, Legacy NDC, 2 package rows | 20220604_5f5ebb63-6ac5-4fb4-bcc1-d069c123eb18.zip |
| 63323-402 | AZTREONAM (AZTREONAM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC
] | 4 | Current NDC, Legacy NDC, 2 package rows | 20220602_302fd27d-0a22-44ea-91fb-1b1ffcf17a1f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-402-01 | 63323040201 | 1 in 1 VIAL | | | | | | Historical |
| 63323-402-03 | 63323040203 | 1 in 1 VIAL | | | | | | Historical |
| 63323-402-20 | 63323040220 | 10 VIAL in 1 TRAY (63323-402-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63323-402-01) | 10 vial | 2009-11-05 | 0000-00-00 | No | No | Current |
| 63323-402-24 | 63323040224 | 10 VIAL in 1 TRAY (63323-402-24) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63323-402-41) | 10 vial | 2009-11-05 | 0000-00-00 | No | No | Current |
| 63323-402-30 | 63323040230 | 10 VIAL in 1 TRAY (63323-402-30) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63323-402-03) | 10 vial | 2009-11-05 | 0000-00-00 | No | No | Current |
| 63323-402-41 | 63323040241 | 1 in 1 VIAL | | | | | | Historical |